| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 42,731 | 48,626 | 43,582 | 32,267 | | Cost of Revenue | (12,904) | (24,186) | 37,090 | 34,909 | | | Gross Profit | 55,635 | 72,812 | 6,492 | (2,642) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 66,014 | 78,529 | 23,486 | 23,616 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 4,499 | 4,859 | 5,536 | 5,753 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (14,878) | (10,576) | (22,530) | (32,011) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (13,655) | (10,576) | (22,530) | (32,011) | | Interest Expense | 400 | 340 | 483 | 724 | | Income Before Tax | (14,055) | (10,916) | (23,013) | (32,735) | | Income Tax Expense | 336 | (706) | 840 | 33,406 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,391) | (10,210) | (23,853) | (66,141) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (14,391) | (10,210) | (23,853) | (66,141) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,391) | ($10,210) | ($23,853) | ($66,141) |
|
1.00% Nasdaq 
Income Statement
